FRM
IDXX icon

Fox Run Management’s Idexx Laboratories IDXX Stock Holding History

Fox Run Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.61M Buy
4,967
+3,269
+193% +$1.83M 0.43% 3
2026
Q1 		$946K Buy
1,698
+851
+100% +$546K 0.17% 196
2025
Q4 		$573K Sell
847
-1,227
-59% -$836K 0.09% 442
2025
Q3 		$1.33M Sell
2,074
-548
-21% -$333K 0.21% 122
2025
Q2 		$1.41M Buy
+2,622
New +$1.25M 0.23% 93
2024
Q4 		– Sell
-920
Closed -$465K – 1007
2024
Q3 		$465K Sell
920
-783
-46% -$380K 0.1% 387
2024
Q2 		$830K Buy
+1,703
New +$855K 0.16% 238
2024
Q1 		– Sell
-459
Closed -$255K – 914
2023
Q4 		$255K Buy
+459
New +$215K 0.07% 553
2023
Q3 		– Sell
-1,079
Closed -$542K – 830
2023
Q2 		$542K Sell
1,079
-186
-15% -$89.1K 0.15% 260
2023
Q1 		$633K Buy
+1,265
New +$605K 0.21% 161
2022
Q3 		– Sell
-1,672
Closed -$586K – 713
2022
Q2 		$586K Buy
+1,672
New +$682K 0.29% 86
2021
Q3 		– Sell
-1,026
Closed -$648K – 547
2021
Q2 		$648K Buy
+1,026
New +$567K 0.59% 10
2019
Q4 		– Sell
-953
Closed -$259K – 455
2019
Q3 		$259K Buy
+953
New +$265K 0.24% 210
2018
Q4 		– Sell
-1,137
Closed -$284K – 605
2018
Q3 		$284K Buy
+1,137
New +$276K 0.12% 370
2018
Q1 		– Sell
-4,664
Closed -$729K – 807
2017
Q4 		$729K Sell
4,664
-1,236
-21% -$195K 0.21% 146
2017
Q3 		$917K Buy
5,900
+2,900
+97% +$458K 0.26% 89
2017
Q2 		$484K Buy
3,000
+500
+20% +$81.2K 0.17% 230
2017
Q1 		$387K Sell
2,500
-1,800
-42% -$248K 0.16% 271
2016
Q4 		$504K Buy
+4,300
New +$491K 0.26% 123

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Fox Run Management's IDXX Position: Q2 2026 in Review

Fox Run Management increased its Idexx Laboratories (IDXX) stake by 193% in Q2 2026, buying an estimated $1.83M and bringing the position to 4,967 shares worth $2.61M. The position accounts for 0.43% of the portfolio, ranked #3.

Fox Run Management first reported a position in IDXX in Q4 2016 and has held it in 19 quarters since. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Fox Run Management held 4,967 shares of Idexx Laboratories worth $2.61M as of Q2 2026.
  • Fox Run Management bought 3,269 Idexx Laboratories shares in Q2 2026, an estimated $1.83M.
  • Idexx Laboratories made up 0.43% of Fox Run Management's portfolio in Q2 2026, its #3 holding.
  • Fox Run Management first reported a position in Idexx Laboratories in Q4 2016 and has held it in 19 quarters since.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.